Use of Immune Checkpoint Inhibitors in the Treatment of High-Risk, Early-Stage Triple-Negative Breast Cancer: ASCO Guideline Rapid Recommendation Update Q and A
JCO ONCOLOGY PRACTICE（2022）
关键词
immune checkpoint inhibitors,breast cancer,high-risk,early-stage,triple-negative
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要